<DOC>
	<DOCNO>NCT01631669</DOCNO>
	<brief_summary>Hypotheses : H1 : Celecoxib , give less five day injury result statistical decrease incidence and/or severity radiographically apparent Heterotopic Ossification compare control . H2a : A biomarker profile accurately predict patient treatment group respond Celecoxib prophylaxis Heterotopic Ossification . H2b : A biomarker profile accurately predict patient control group high risk develop Heterotopic Ossification</brief_summary>
	<brief_title>Celecoxib Primary Prophylaxis Combat-Related Heterotopic Ossification</brief_title>
	<detailed_description>This study prospective , randomize , control clinical trial .</detailed_description>
	<mesh_term>Ossification , Heterotopic</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . ISS ≥9 ( traumatic transtibial amputation ISS 9 ) 2 . Extremity Wound ≥75cm2 require operative intervention 3 . Minimal age 18 year The following comorbidities result exclusion study : 1 . Coronary Artery Disease , 2 . Diabetes Mellitus ( IDDM T2DM ) , 3 . Peripheral Vascular Disease , 4 . Age &gt; 65 , 5 . Connective tissue disorder , 6 . Immunosuppression , 7 . Clinicallyevident peptic ulcer disease , 8 . Substantial renal dysfunction ( assessed serum creatinine &gt; 1.5 calculate creatinine clearance &lt; 50 ) , 9 . Spineinjured patient recently receive go receive spinal fusion determine evaluate neurosurgeon orthopaedic spine surgeon LRMC , 10 . Severe penetrate hemorrhagic traumatic brain injury , 11 . Endoscopic gastrointestinal intervention , 12 . Pregnancy woman childbearing take pregnancy test effective method birth control . 13 . Known hypersensitivity Celebrex , Aspirin , NSAIDs , Sulfonamides . 14 . History od Asthma , Urticaria , allergictype reaction take Aspirin NSAIDs . 15 . Hepatic Impairment 16 . Warfarin 17 . Lithium 18 . Drugs know inhibit CYP2C9 Liver Enzymes 19 . Subjects know suspected poor CYP2C9 metabolizers 20 . Concomitant use ACE Inhibitors Angiotension II Antagonists</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Ossification</keyword>
	<keyword>Heterotopic Ossification</keyword>
</DOC>